ArticleAdvances in therapy2026

Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel as Second-Line Treatment for Large B Cell Lymphoma in the United States.

Kristen A Deger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.